Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
528.275 USD 0.23 ( 0.04%)
Last update at 2026-11-09T15:34:00Z
VOLUME
20883
Market Cap
6619.54M
P/E
25.45

Momentum Score

…

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
527.55
Low
540.74
High
52 Week Price Range
364.23
Low
556.27
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Chemed Corporation operates two U.S. service businesses: VITAS Healthcare, a hospice and palliative care provider, and Roto-Rooter, a plumbing and water restoration franchise. Long-term growth could be supported by aging demographics, steady demand for home repair, and recurring revenue from Medicare and service contracts, and the company appears positioned with market-leading scale in both segments. Key risks include Medicare reimbursement and regulatory changes, workforce and wage pressures, compliance or litigation in hospice operations, and sensitivity to economic cycles affecting home-service volumes.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
528.05
Dividend Yield
0.47%
Revenue TTM
2595.00M
Revenue Per Share
187.96
Gross Profit TTM
859.31M
Debt / Equity
0.16
ROE
27.11%
Net Debt
80.24M
ROCE
26.43%
Diluted EPS TTM
19.90

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 355.78M 399.46M 350.37M 329.68M 350.31M
Net income 265.24M 302.00M 272.51M 249.62M 268.55M
Selling general administrative 417.19M 424.36M 395.12M 358.73M 366.73M
Selling and marketing expenses - 73.15M 72.20M - -
Gross profit 758.34M 854.35M 798.82M 765.09M 769.80M
Reconciled depreciation 64.84M 63.05M 59.93M 59.17M 59.05M
Ebit 357.53M 401.25M 353.48M 343.50M 343.04M
Ebitda 422.37M 464.29M 414.34M 393.44M 411.23M
Depreciation and amortization 64.84M 63.05M 60.87M 49.94M 68.19M
Non operating income net other - - - - 9.14M
Operating income 338.25M 366.49M 340.57M 343.50M 343.04M
Other operating expenses 2191.73M 2064.79M 1923.85M 1791.47M 1796.22M
Interest expense 1.75M 1.78M 3.11M 4.58M 1.87M
Tax provision 90.54M 97.47M 72.59M 80.06M 81.76M
Interest income 8.74M 14.61M 2.93M 14.20M 6.82M
Net interest income 7.00M 12.83M -1.44M -4.23M -1.49M
Income tax expense 90.54M 97.47M 77.86M 80.06M 81.76M
Total revenue 2529.98M 2431.29M 2264.42M 2134.96M 2139.26M
Total operating expenses 417.19M 487.86M 458.25M 421.59M 426.76M
Cost of revenue 1771.63M 1576.94M 1465.60M 1369.88M 1369.46M
Total other income expense net 17.53M 32.97M 9.80M -13.82M 7.28M
Net income from continuing ops 265.24M 302.00M 244.58M 249.62M 268.55M
Net income applicable to common shares 265.24M 302.00M 272.51M 249.62M 268.55M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1640.01M 1668.58M 1668.10M 1442.01M 1342.72M
Intangible assets 82.76M 92.21M 90.26M 99.73M 108.10M
Other current assets 37.98M 37.04M 43.37M 48.81M 50.06M
Total liab 660.61M 549.58M 560.22M 643.30M 719.45M
Total stockholder equity 979.40M 1118.99M 1107.88M 798.72M 623.27M
Deferred long term liab - - - 1.70M 121.78M
Other current liab 170.61M 191.65M 186.82M 172.71M 39.03M
Common stock 37.59M 37.42M 37.18M 36.80M 36.51M
Capital stock 37.59M 37.42M 37.18M 36.80M 36.51M
Retained earnings 2955.38M 2721.83M 2446.93M 2197.92M 1970.31M
Other liab - - - 143.08M 131.42M
Good will 667.00M 666.74M 585.02M 581.29M 578.59M
Other assets 8.65M -98.79M 53.95M 57.98M 107.02M
Cash 74.52M 178.35M 263.96M 74.13M 32.90M
Cash and equivalents 74.52M 178.35M 263.96M 74.13M 32.90M
Total current liabilities 287.13M 285.69M 312.05M 297.20M 302.40M
Current deferred revenue - - 6.86M 38.61M 152.43M
Net debt 80.24M -37.51M -108.85M 172.88M 290.65M
Short term debt 51.89M 42.31M 54.34M 44.00M 37.91M
Short long term debt - - 15.70M 5.00M -
Short long term debt total 154.76M 140.84M 155.11M 247.01M 323.54M
Other stockholder equity -2015.92M -1640.26M -1376.23M -1436.00M -1383.55M
Property plant equipment 336.81M 328.16M 330.23M 335.38M 318.73M
Total current assets 302.62M 394.75M 500.84M 272.61M 230.29M
Long term investments - - - - 98.88M
Net tangible assets - - - 108.79M -63.41M
Net receivables 182.57M 171.16M 181.51M 139.41M 137.22M
Long term debt - - 0.00M 92.50M 185.00M
Inventory 7.54M 8.19M 12.00M 10.27M 10.11M
Accounts payable 53.46M 44.15M 64.03M 41.88M 73.02M
Accumulated other comprehensive income 2.35M 2.22M 2.08M - -
Common stock total equity - - - - 36.51M
Retained earnings total equity - - - - 1970.31M
Treasury stock - - - - -2430.09M
Non currrent assets other 8.65M 186.72M 161.74M 153.00M 8.14M
Non current assets total 1337.39M 1273.83M 1167.25M 1169.40M 1112.44M
Capital lease obligations 143.76M 140.84M 139.41M 149.51M 138.54M
Long term debt total 0.00M 0.00M 0.00M 92.50M 185.00M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -143.91M -68.46M -59.40M -57.76M
Change to liabilities - - - 15.34M 9.83M
Total cashflows from investing activities -59.34M -143.91M -60.64M -59.40M -57.76M
Net borrowings 10.97M -15.75M -81.75M -99.38M 196.88M
Total cash from financing activities -432.77M -359.19M -79.83M -209.25M -380.62M
Change to operating activities - - - -45.26M -4.79M
Net income 265.24M 302.00M 272.51M 249.62M 268.55M
Change in cash -103.83M -85.61M 189.83M 41.23M -129.78M
Begin period cash flow 178.35M 263.96M 74.13M 32.90M 162.68M
End period cash flow 74.52M 178.35M 263.96M 74.13M 32.90M
Total cash from operating activities 388.27M 417.50M 330.30M 309.89M 308.60M
Depreciation 64.84M 63.05M 60.87M 59.17M 59.05M
Other cashflows from investing activities 3.68M 3.02M 0.21M -2.08M 0.92M
Dividends paid 31.70M 27.09M 23.50M 22.02M 22.02M
Change to inventory 0.65M 3.83M -1.73M -0.16M -3.01M
Change to account receivables -11.60M 10.68M -41.49M -2.41M -8.43M
Sale purchase of stock -431.50M -361.39M -67.70M -114.52M -576.04M
Other cashflows from financing activities -7.69M 45.04M 93.12M 236.53M -0.17M
Change to netincome - - - 34.24M 7.49M
Capital expenditures 62.80M 49.53M 56.85M 57.33M 58.67M
Change receivables - - - - -8.43M
Cash flows other operating - - - - -35.03M
Cash and cash equivalents changes - - - - -129.78M
Change in working capital 23.71M 8.13M -39.31M -33.49M -26.80M
Stock based compensation 4.89M 32.03M 30.08M -0.02M 31.42M
Other non cash items 35.54M 16.42M 14.18M 37.94M -7.85M
Free cash flow 325.48M 367.97M 273.44M 252.56M 249.92M

Peer Comparison*

Sector: Healthcare Industry: Medical Care Facilities

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CHE
Chemed Corp
0.23
0.04%
528.27 25.45 18.76 2.55 8.09 2.69 15.90
HCA
HCA Healthcare, Inc.
8.00
1.62%
502.99 14.27 13.46 1.21 291.34 1.83 8.99
THC
Tenet Healthcare Corporation
5.54
1.95%
288.87 10.08 12.66 0.96 4.57 1.43 5.80
FSNUY
Fresenius SE & Co KGaA ADR
0.27
1.86%
14.79 16.87 9.44 0.42 0.78 0.79 5.37
JDHIY
JD Health International Inc
0.29
5.59%
5.57 62.50 35.97 0.30 2.32 0.16 3.90

Profile*

Chemed Corp

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments. The company offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company also provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

2600 First Financial Center, Cincinnati, OH, United States, 45202-4726

513 762 6690

15811

Name Title Year Born
Mr. Kevin J. McNamara CEO, Pres & Director 1954
Mr. David P. Williams Exec. VP & CFO 1961
Mr. Michael D. Witzeman CPA, MBA VP & Controller 1971
Mr. Nicholas Michael Westfall Exec. VP 1979
Ms. Lisa A. Reinhard VP, Chief Admin. Officer & Assistant Sec. NA
Sherri Warner Director of Investor Relations NA
Mr. Brian C. Judkins VP, Sec. & Chief Legal Officer 1981
Mr. Thomas C. Hutton VP & Director 1951
Mr. Kevin J. McNamara CEO, President & Director 1955
Mr. Michael D. Witzeman CPA, MBA Executive VP, Controller, Principal Accounting Officer & CFO 1971

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…